MYLAN 186 (Clonidine 0.2 mg)
Pill imprint MYLAN 186 has been identified as Clonidine hydrochloride 0.2 mg.
Clonidine is used in the treatment of opiate withdrawal; anxiety; adhd; high blood pressure; alcohol withdrawal (and more), and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy. Clonidine 0.2 mg is not a controlled substance under the Controlled Substance Act (CSA).
- MYLAN 186
- 0.2 mg
- 7.00 mm
- Prescription only
- Drug Class:
- Antiadrenergic agents, centrally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- ammonium chloride
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|51079-0300||UDL Laboratories Inc|
|54569-1853||A-S Medication Solutions, LLC (repackager)|
|68115-0088||Dispensexpress Inc (repackager)|
|49999-0258||Lake Erie Medical and Surgical Supply (repackager)|
|55289-0074||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about clonidine
- Clonidine extended-release tablets
- Clonidine patches
- Clonidine suspension
- Clonidine tablets
- Clonidine transdermal
- More (3) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.